ARQL Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ARQL Shares Outstanding History and ARQL YTD Return |
ARQL Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ARQL Shares Outstanding History and ARQL YTD Return |
ARQL Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+22.98% CAGR Mouse over chart for data details
|
ARQL Stock Price Chart |
About ArQule Inc. |
ArQule is a biopharmaceutical company engaged in the research and development of therapeutics to treat cancers and rare diseases. Co.'s clinical pipeline includes: ARQ 531, which is a reversible dual inhibitor of both wild type and C481S-mutant Bruton's tyrosine kinase for B-cell malignancies refractory to other therapeutic options; Miransertib, which is a selective inhibitor of protein kinase B (AKT) in combination with the hormonal therapy, anastrozole; ARQ 751, which is a selective inhibitor of AKT for solid tumors harboring AKT, phosphoinositide 3-kinase or phosphatase and tensin homolog (PTEN) mutations or that are PTEN null; and Derazantinib, which is a multi-kinase inhibitor. We show 41 historical shares outstanding datapoints in our ARQL shares outstanding history coverage, used to compute ARQL market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARQL market cap history over the course of time is important for investors interested in comparing ARQL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARQL versus a peer is one thing; comparing ARQL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARQL can fluctuate over the course of history. With this page we aim to empower investors researching ARQL by allowing them to research the ARQL market cap history. |
ARQL Current Stock Quote |
Free ARQL Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
ARQL Share Performance |
Market Cap Peers |
ArQule (ARQL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ARQT Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.